These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 15899605

  • 1. [Pharmacological treatment in severe dementia].
    Jouanny P, Belliard S, Bentué-Ferrer D, Michel O, Allain H.
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S51-5. PubMed ID: 15899605
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of memantine in moderate-to-severe Alzheimer disease: the evidence to date.
    Bullock R.
    Alzheimer Dis Assoc Disord; 2006 Mar; 20(1):23-9. PubMed ID: 16493232
    [Abstract] [Full Text] [Related]

  • 3. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary.
    Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP.
    Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561
    [Abstract] [Full Text] [Related]

  • 4. Lower Barthel Index scores predict less prescription of pharmacological therapy in elderly patients with Alzheimer disease.
    Formiga F, Fort I, Robles MJ, Rodriguez D, Regalado P.
    Dement Geriatr Cogn Disord; 2010 Jan; 29(3):198-203. PubMed ID: 20332637
    [Abstract] [Full Text] [Related]

  • 5. [Memantine for treatment of behavioural disturbances and psychotic symptoms in moderate to moderately severe Alzheimer dementia: a naturalistic study in outpatient services in Austria].
    Schmidt R, Baumhackl U, Berek K, Brücke T, Kapeller P, Lechner A, Rainer M, Stögerer EM.
    Neuropsychiatr; 2010 Jan; 24(2):125-31. PubMed ID: 20605008
    [Abstract] [Full Text] [Related]

  • 6. [Psychobehavioral disorders in severe dementia].
    Derouesné C.
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S5-13. PubMed ID: 15899600
    [Abstract] [Full Text] [Related]

  • 7. [Non-pharmacologic approach in severe dementia].
    Pancrazi MP, Métais P.
    Psychol Neuropsychiatr Vieil; 2005 Mar; 3 Suppl 1():S42-50. PubMed ID: 15899604
    [Abstract] [Full Text] [Related]

  • 8. [Current antidementive therapy].
    Perneczky R, Kurz A.
    MMW Fortschr Med; 2004 May 24; 146 Spec No 2():53-6. PubMed ID: 15376702
    [Abstract] [Full Text] [Related]

  • 9. [Outpatient treatment of patients suffering from Alzheimer dementia. Two exploratory studies on the characteristics of therapy in medical practice].
    Haupt M, Rosenfeld S, Stoppe G.
    MMW Fortschr Med; 2004 Aug 05; 146 Suppl 2():51-6. PubMed ID: 16739359
    [Abstract] [Full Text] [Related]

  • 10. [Modern therapy for dementia].
    Padberg F, Möller HJ, Bottlender R, Hampel H.
    MMW Fortschr Med; 2005 May 17; 147 Spec No 2():71-4, 76-7. PubMed ID: 15968877
    [Abstract] [Full Text] [Related]

  • 11. [Starting Alzheimer therapy in early stages whenever possible. Activities of daily living remain intact longer].
    Fuchsberger T, Padberg F, Faltraco F, Möller HJ, Hampel H.
    MMW Fortschr Med; 2002 May 16; 144(20):36-9. PubMed ID: 12119881
    [Abstract] [Full Text] [Related]

  • 12. Memantine for dementia?
    Drug Ther Bull; 2003 Oct 16; 41(10):73-6. PubMed ID: 14593973
    [Abstract] [Full Text] [Related]

  • 13. [Assessment of dementia and use of anti-dementia drugs in nursing homes].
    Engedal K.
    Tidsskr Nor Laegeforen; 2005 May 04; 125(9):1188-90. PubMed ID: 15880157
    [Abstract] [Full Text] [Related]

  • 14. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A.
    Neuropsychiatr; 2007 May 04; 21(3):230-3. PubMed ID: 17915184
    [Abstract] [Full Text] [Related]

  • 15. [Alzheimer dementia. Memantine: value for patient and caregivers].
    MMW Fortschr Med; 2009 Nov 05; 151(45):44-5. PubMed ID: 19960725
    [No Abstract] [Full Text] [Related]

  • 16. Memantine (Ebixa) in clinical practice - results of an observational study.
    Calabrese P, Essner U, Forstl H.
    Dement Geriatr Cogn Disord; 2007 Nov 05; 24(2):111-7. PubMed ID: 17622714
    [Abstract] [Full Text] [Related]

  • 17. Outcomes for clinical trials in mild-to-moderate dementia to evaluate drugs with presumably symptomatic effects.
    Frolich L.
    J Nutr Health Aging; 2007 Nov 05; 11(4):357-8. PubMed ID: 17653499
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological treatments of behavioral and psychological symptoms of dementia in Alzheimer's disease: role of acetylcholinesterase inhibitors and memantine.
    Desmidt T, Hommet C, Camus V.
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep 01; 14(3):300-6. PubMed ID: 27651011
    [Abstract] [Full Text] [Related]

  • 19. Specific symptomatic changes following donepezil treatment of Alzheimer's disease: a multi-centre, primary care, open-label study.
    Rockwood K, Black S, Bedard MA, Tran T, Lussier I, TOPS Study Investigators.
    Int J Geriatr Psychiatry; 2007 Apr 01; 22(4):312-9. PubMed ID: 17006874
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological treatment of dementia.
    Schwarz S, Froelich L, Burns A.
    Curr Opin Psychiatry; 2012 Nov 01; 25(6):542-50. PubMed ID: 22992546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.